Sangmyung Innovation
Clinical trials sponsored by Sangmyung Innovation, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Eye implant could restore sight after retinal vein blockage Results expected Jul 2027 (estimated)
-
Eye implant could restore sight after retinal vein blockage
Disease control Recruiting nowThis phase 3 trial tests a single injection of SMO1, a dexamethasone implant placed inside the eye, for people with macular edema (swelling) caused by a blocked retinal vein. The study compares SMO1 to an existing dexamethasone implant to see which better improves vision and redu…
Phase 3 • Sponsor: SANGMYUNG innovation • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New pill may boost vision in wet AMD patients
Disease control Recruiting nowThis Phase 3 trial tests whether adding an SMZ1 tablet to standard ranibizumab eye injections improves vision more than injections alone in people with wet age-related macular degeneration (AMD). Participants receive either SMZ1 or a placebo tablet twice daily for 12 months, alon…
Phase 3 • Sponsor: SANGMYUNG innovation • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC